CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML
NCT06470841
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
85
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
DRUG:
CHG Combined With Venetoclax and Azacytidine
Sponsor
Navy General Hospital, Beijing